Dr. Joseph K. Han, MD
ENT (Otolaryngology) (Otolaryngology Physician)
600 Gresham Dr, Suite 1100
Norfolk, VA 23507
Who else practices at this address →
Norfolk city is a federal dental shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Medical College of Pennsylvania (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 146
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Medical College of Pennsylvania
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otolaryngology Physician primary
VA license 0101234835 -
Facial Plastic Surgery Physician
VA license 0101234835 -
Otology & Neurotology Physician
VA license 0101234835 -
Pediatric Otolaryngology Physician
VA license 0101234835 -
Plastic Surgery within the Head & Neck (Otolaryngology) Physician
VA license 0101234835
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sentara Norfolk General Hospital Norfolk, VA
- Sentara Leigh Hospital Norfolk, VA
- Sentara Obici Hospital Suffolk, VA
Medical groups
- Evms Academic Physicians and Surgeons Health Services Foundation (232 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 146
- Services billed
- 696
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Diagnostic exam of nasal passages using an endoscope | 224 | 135 |
| Established patient office or other outpatient visit, 20-29 minutes | 122 | 93 |
| Established patient office or other outpatient visit, 30-39 minutes | 58 | 49 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 44 | 30 |
| Computer-assisted procedure outside membrane covering brain | 25 | 25 |
| New patient office or other outpatient visit, 45-59 minutes | 23 | 23 |
| Exploration of nasal sinus using an endoscope | 17 | 17 |
| Removal of nasal sinus tissue using an endoscope | 16 | 16 |
| Removal of nasal sinus using an endoscope | 15 | 15 |
| Removal of sphenoid nasal sinus tissue using an endoscope | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Mupirocin Other prescribers in Norfolk, VA | 97 |
| Ipratropium Bromide Other prescribers in Norfolk, VA | 72 |
| Montelukast Sodium Other prescribers in Norfolk, VA | 24 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Norfolk, VA | 24 |
| Prednisone Other prescribers in Norfolk, VA | 23 |
| Fluticasone Propionate Other prescribers in Norfolk, VA | 22 |
| Dupixent Syringe (dupilumab) Other prescribers in Norfolk, VA | 16 |
| Doxycycline Hyclate Other prescribers in Norfolk, VA | 16 |
| Xhance (fluticasone propionate) Other prescribers in Norfolk, VA | 15 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Norfolk, VA | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 211 payments worth $304,622 in total to this clinician.
| GlaxoSmithKline, LLC. | $126,653 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $64,157 |
| Genzyme Corporation | $45,838 |
| Regeneron Healthcare Solutions, Inc. | $19,670 |
| Optinose US, Inc. | $18,432 |
| Sanofi US Services Inc. | $11,950 |
| Insmed, Inc. | $11,870 |
| Paratek Pharmaceuticals, Inc. | $3,693 |
| Compensation for services other than consulting (speaking, faculty) | $172,784 |
|---|---|
| Consulting Fee | $106,578 |
| Travel and Lodging | $19,939 |
| Food and Beverage | $5,296 |
| Education | $25.70 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $24,795 |
| GlaxoSmithKline, LLC. Oct 3, 2025 | Consulting Fee | $14,400 |
| GlaxoSmithKline, LLC. Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) | $14,045 |
| Sanofi US Services Inc. Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) | $11,926 |
| Regeneron Healthcare Solutions, Inc. Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $9,849 |
| Genzyme Corporation Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $9,849 |
| Insmed, Inc. Apr 4, 2025 | Consulting Fee | $8,916 |
| GlaxoSmithKline, LLC. May 20, 2025 | Consulting Fee | $8,400 |
| GlaxoSmithKline, LLC. Feb 7, 2025 | Consulting Fee | $8,125 |
| Genzyme Corporation Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,973 |
All 139 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Dec 24, 2025 | Consulting Fee | $4,000 |
| AstraZeneca Pharmaceuticals LP Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,520 |
| GlaxoSmithKline, LLC. Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) | $14,045 |
| GlaxoSmithKline, LLC. Dec 15, 2025 | Consulting Fee | $1,600 |
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $938 |
| AstraZeneca Pharmaceuticals LP Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $2,150 |
| GlaxoSmithKline, LLC. Dec 8, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $6,400 |
| AstraZeneca Pharmaceuticals LP Dec 1, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Nov 26, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $1,074 |
| AstraZeneca Pharmaceuticals LP Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $2,150 |
| AstraZeneca Pharmaceuticals LP Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $7,040 |
| GlaxoSmithKline, LLC. Nov 15, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Oceanside, CA · in-kind | $1,840 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Vienna, VA · in-kind Company’s descriptionSpeaker Expenses | $433 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Vienna, VA · in-kind Company’s descriptionSpeaker Expenses | $305 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Vienna, VA · in-kind Company’s descriptionSpeaker Expenses | $259 |
| GlaxoSmithKline, LLC. Nov 7, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Indianapolis, IN | $69.50 |
| Genzyme Corporation Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology · in-kind Company’s descriptionIf more than one clinical reprint is received on the same day, the reported transfer of value will reflect the aggregate total. | $250 |
| AstraZeneca Pharmaceuticals LP Nov 3, 2025 | Consulting Fee TEZSPIRE · Respiratory | $806 |
| AstraZeneca Pharmaceuticals LP Nov 1, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| AstraZeneca Pharmaceuticals LP Oct 27, 2025 | Consulting Fee TEZSPIRE · Respiratory Company’s descriptionResearch Related Service | $2,954 |
| GlaxoSmithKline, LLC. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $6,400 |
| Paratek Pharmaceuticals, Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) NUZYRA · ANTIBIOTIC | $3,300 |
| AstraZeneca Pharmaceuticals LP Oct 22, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Chesapeake, VA · in-kind Company’s descriptionSpeaker Expenses | $26.60 |
| AstraZeneca Pharmaceuticals LP Oct 21, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Norfolk, VA · in-kind Company’s descriptionSpeaker Expenses | $23.80 |
| Optinose US, Inc. Oct 15, 2025 | Travel and Lodging Xhance · Otolaryngology (Ear, Nose, Throat) · travel to NEW YORK, NY | $399 |
| Paratek Pharmaceuticals, Inc. Oct 15, 2025 | Travel and Lodging NUZYRA · ANTIBIOTIC · travel to NEW YORK, NY | $260 |
| GlaxoSmithKline, LLC. Oct 14, 2025 | Consulting Fee | $2,400 |
| AstraZeneca Pharmaceuticals LP Oct 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $709 |
| AstraZeneca Pharmaceuticals LP Oct 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $345 |
| AstraZeneca Pharmaceuticals LP Oct 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $54.11 |
| GlaxoSmithKline, LLC. Oct 10, 2025 | Consulting Fee | $2,800 |
| GlaxoSmithKline, LLC. Oct 9, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Indianapolis, IN · in-kind | $1,065 |
| GlaxoSmithKline, LLC. Oct 9, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Indianapolis, IN · in-kind | $174 |
| GlaxoSmithKline, LLC. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Oct 8, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to San Francisco, CA | $173 |
| GlaxoSmithKline, LLC. Oct 8, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Norfolk, VA | $23.80 |
| Insmed, Inc. Oct 6, 2025 | Consulting Fee | $1,486 |
| Insmed, Inc. Oct 6, 2025 | Consulting Fee | $372 |
| GlaxoSmithKline, LLC. Oct 3, 2025 | Consulting Fee | $14,400 |
| GlaxoSmithKline, LLC. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Sep 18, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to San Francisco, CA · in-kind | $590 |
| GlaxoSmithKline, LLC. Sep 18, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to San Francisco, CA · in-kind | $322 |
| Genzyme Corporation Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $24,795 |
| AstraZeneca Pharmaceuticals LP Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,050 |
| AstraZeneca Pharmaceuticals LP Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| GlaxoSmithKline, LLC. Aug 14, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Richmond, VA | $167 |
| GlaxoSmithKline, LLC. Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $3,200 |
| AstraZeneca Pharmaceuticals LP Aug 1, 2025 | Consulting Fee | $806 |
| Medtronic, Inc. Jul 25, 2025 | Consulting Fee | $419 |
| Merck Sharp & Dohme LLC Jul 18, 2025 | Education KEYTRUDA · ONCOLOGY · in-kind | $25.70 |
| GlaxoSmithKline, LLC. Jul 17, 2025 | Consulting Fee | $3,600 |
| GlaxoSmithKline, LLC. Jul 17, 2025 | Consulting Fee | $3,600 |
| AstraZeneca Pharmaceuticals LP Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| AstraZeneca Pharmaceuticals LP Jul 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to San Diego, CA · in-kind Company’s descriptionSpeaker Expenses | $712 |
| AstraZeneca Pharmaceuticals LP Jul 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to San Diego, CA · in-kind Company’s descriptionSpeaker Expenses | $434 |
| AstraZeneca Pharmaceuticals LP Jul 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to San Diego, CA · in-kind Company’s descriptionSpeaker Expenses | $122 |
| AstraZeneca Pharmaceuticals LP Jul 11, 2025 | Consulting Fee TEZSPIRE · Respiratory | $1,611 |
| GlaxoSmithKline, LLC. Jul 7, 2025 | Travel and Lodging travel to San Francisco, CA | $770 |
| GlaxoSmithKline, LLC. Jul 7, 2025 | Travel and Lodging travel to San Francisco, CA | $177 |
| AstraZeneca Pharmaceuticals LP Jul 1, 2025 | Consulting Fee TEZSPIRE · Respiratory Company’s descriptionResearch Related Service | $2,417 |
| AstraZeneca Pharmaceuticals LP Jul 1, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| GlaxoSmithKline, LLC. Jun 6, 2025 | Consulting Fee | $3,200 |
| Sanofi US Services Inc. Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) | $11,926 |
| Sanofi US Services Inc. Jun 5, 2025 | Travel and Lodging travel to Atlanta, GA | $24.00 |
| Optinose US, Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $4,500 |
| Optinose US, Inc. May 22, 2025 | Travel and Lodging Xhance · Otolaryngology (Ear, Nose, Throat) · travel to ALBANY, NY | $1,011 |
| AstraZeneca Pharmaceuticals LP May 21, 2025 | Consulting Fee TEZSPIRE · Respiratory | $1,880 |
| GlaxoSmithKline, LLC. May 20, 2025 | Consulting Fee | $8,400 |
| GlaxoSmithKline, LLC. May 11, 2025 | Travel and Lodging travel to Virginia Beach, VA · in-kind | $151 |
| Regeneron Healthcare Solutions, Inc. Apr 29, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to NORFOLK, VA · in-kind | $25.20 |
| Regeneron Healthcare Solutions, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,159 |
| Regeneron Healthcare Solutions, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,876 |
| AstraZeneca Pharmaceuticals LP Apr 11, 2025 | Consulting Fee TEZSPIRE · Respiratory Company’s descriptionResearch Related Service | $1,343 |
| Medtronic, Inc. Apr 11, 2025 | Travel and Lodging FUSION · Image Guided Surgery Products · travel to Jacksonville, FL · in-kind | $206 |
| Medtronic, Inc. Apr 11, 2025 | Travel and Lodging FUSION · Image Guided Surgery Products · travel to Jacksonville, FL · in-kind | $125 |
| Medtronic, Inc. Apr 11, 2025 | Travel and Lodging FUSION · Image Guided Surgery Products · travel to Jacksonville, FL · in-kind | $27.81 |
| Optinose US, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $1,200 |
| Optinose US, Inc. Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $1,500 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Consulting Fee | $5,200 |
| Insmed, Inc. Apr 4, 2025 | Consulting Fee | $8,916 |
| GlaxoSmithKline, LLC. Apr 4, 2025 | Travel and Lodging travel to Leon, Mexico · in-kind | $893 |
| GlaxoSmithKline, LLC. Apr 4, 2025 | Travel and Lodging travel to Norfolk, VA · in-kind | $628 |
| GlaxoSmithKline, LLC. Apr 4, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $206 |
| AstraZeneca Pharmaceuticals LP Apr 2, 2025 | Consulting Fee | $537 |
| GlaxoSmithKline, LLC. Apr 2, 2025 | Travel and Lodging travel to Virginia Beach, VA | $372 |
| AstraZeneca Pharmaceuticals LP Apr 1, 2025 | Consulting Fee | $537 |
| GlaxoSmithKline, LLC. Mar 31, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $980 |
| GlaxoSmithKline, LLC. Mar 31, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $31.02 |
| AstraZeneca Pharmaceuticals LP Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| AstraZeneca Pharmaceuticals LP Mar 21, 2025 | Consulting Fee TEZSPIRE · Respiratory Company’s descriptionResearch Related Service | $3,088 |
| Genzyme Corporation Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,973 |
| Medtronic, Inc. Mar 20, 2025 | Travel and Lodging FUSION · Image Guided Surgery Products · travel to Jacksonville, FL · in-kind | $467 |
| Genzyme Corporation Mar 20, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Richmond, VA | $162 |
| Medtronic, Inc. Mar 20, 2025 | Travel and Lodging FUSION · Image Guided Surgery Products · travel to Jacksonville, FL · in-kind | $35.07 |
| Genzyme Corporation Mar 20, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Richmond, VA | $5.03 |
| Genzyme Corporation Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $9,849 |
| GlaxoSmithKline, LLC. Mar 19, 2025 | Consulting Fee | $2,400 |
| Genzyme Corporation Mar 19, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Hackensack, NJ · in-kind | $512 |
| AstraZeneca Pharmaceuticals LP Mar 19, 2025 | Consulting Fee TEZSPIRE · Respiratory | $269 |
| Genzyme Corporation Mar 19, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Hackensack, NJ · in-kind | $166 |
| Genzyme Corporation Mar 19, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Hackensack, NJ | $74.88 |
| Genzyme Corporation Mar 19, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Hackensack, NJ | $12.00 |
| Optinose US, Inc. Mar 18, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $2,100 |
| Optinose US, Inc. Mar 18, 2025 | Travel and Lodging Xhance · Otolaryngology (Ear, Nose, Throat) · travel to CHESAPEAKE, VA | $28.00 |
| Optinose US, Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $4,500 |
| AstraZeneca Pharmaceuticals LP Mar 12, 2025 | Consulting Fee TEZSPIRE · Respiratory | $2,148 |
| Optinose US, Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) Xhance · Otolaryngology (Ear, Nose, Throat) | $1,350 |
| Optinose US, Inc. Mar 12, 2025 | Travel and Lodging Xhance · Otolaryngology (Ear, Nose, Throat) · travel to ALBANY, NY | $982 |
| AstraZeneca Pharmaceuticals LP Mar 7, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $806 |
| AstraZeneca Pharmaceuticals LP Mar 6, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $403 |
| AstraZeneca Pharmaceuticals LP Mar 2, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to San Diego, CA · in-kind Company’s descriptionSpeaker Expenses | $455 |
| AstraZeneca Pharmaceuticals LP Mar 2, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to San Diego, CA · in-kind Company’s descriptionSpeaker Expenses | $360 |
| AstraZeneca Pharmaceuticals LP Mar 2, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to San Diego, CA · in-kind Company’s descriptionSpeaker Expenses | $12.00 |
| Genzyme Corporation Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology · in-kind Company’s descriptionIf more than one clinical reprint is received on the same day, the reported transfer of value will reflect the aggregate total. | $500 |
| Insmed, Inc. Feb 28, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $360 |
| Genzyme Corporation Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology · in-kind Company’s descriptionIf more than one clinical reprint is received on the same day, the reported transfer of value will reflect the aggregate total. | $250 |
| Insmed, Inc. Feb 28, 2025 | Travel and Lodging travel to Norfolk, VA · in-kind | $12.00 |
| Insmed, Inc. Feb 26, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $160 |
| Insmed, Inc. Feb 21, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $500 |
| Regeneron Healthcare Solutions, Inc. Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,111 |
| Regeneron Healthcare Solutions, Inc. Feb 20, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to NORTH BETHESDA, MD · in-kind | $12.00 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| GlaxoSmithKline, LLC. Feb 7, 2025 | Consulting Fee | $8,125 |
| Regeneron Healthcare Solutions, Inc. Feb 7, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to FREDERICKSBURG, VA · in-kind | $210 |
| Regeneron Healthcare Solutions, Inc. Feb 7, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to FREDERICKSBURG, VA · in-kind | $5.32 |
| GlaxoSmithKline, LLC. Feb 3, 2025 | Travel and Lodging NUCALA · IMMUNOLOGY · travel to Owings Mills, MD | $12.00 |
| GlaxoSmithKline, LLC. Jan 31, 2025 | Consulting Fee | $4,800 |
| GlaxoSmithKline, LLC. Jan 31, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,403 |
| AstraZeneca Pharmaceuticals LP Jan 29, 2025 | Consulting Fee TEZSPIRE · Respiratory | $1,611 |
| GlaxoSmithKline, LLC. Jan 21, 2025 | Consulting Fee | $2,400 |
| AstraZeneca Pharmaceuticals LP Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| GlaxoSmithKline, LLC. Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) NUCALA · IMMUNOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Jan 9, 2025 | Travel and Lodging travel to MERIDA, Mexico · in-kind | $1,007 |
| Regeneron Healthcare Solutions, Inc. Jan 9, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to FREDERICKSBURG, VA · in-kind | $255 |
| AstraZeneca Pharmaceuticals LP Jan 8, 2025 | Consulting Fee TEZSPIRE · Respiratory | $4,565 |
| Regeneron Healthcare Solutions, Inc. Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $9,849 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 10 industry-funded studies in 2025, from 5 companies. The companies reported $144,432 in research payments for these studies, mostly to the institutions running them.
- A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps
Sanofi US Services Inc. · Completed · NCT06454240 - Dupilumab in CRSsNP
Sanofi US Services Inc. · Completed · NCT04678856 - A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
Sanofi US Services Inc. · Completed · NCT06691113 - A phase 3, 52-week, randomized, double-blind, placebo-controlled, para
GlaxoSmithKline, LLC. - A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyposis WAYPOINT
AstraZeneca Pharmaceuticals LP - Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT04959448 - A randomised, double-blind, parallel group phase iii study to assess t
GlaxoSmithKline, LLC. - EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
Genzyme Corporation · Completed · NCT04998604 - Dupilumab in Allergic Fungal Rhinosinusitis (AFRS)
Sanofi US Services Inc. · Completed · NCT04684524 - A Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab Compared to Mepolizumab in the Treatment of Eosinophilic Granulomatosis with…
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.